Literature DB >> 3259894

Radiotherapy in benign orbital disease. II: Ophthalmic Graves' disease and orbital histiocytosis X.

A N Harnett1, D Doughty, A Hirst, P N Plowman.   

Abstract

Ophthalmic Graves' disease and histiocytosis X involving the orbit are occasionally refractory to treatment, so that vision may be threatened. In these situations megavoltage external beam radiotherapy should be employed, and the indications for this treatment are discussed. A highly accurate technique is described, using precise planning with information obtained from high definition CT scans, a complete patient head shell for immobilisation, and modern megavoltage radiotherapy treatment machines. As a result the dose to the lens is minimised (to a maximum of 10% of the prescribed dose), and late morbidity will be small. Two cases are described to illustrate this procedure and the response to treatment.

Entities:  

Mesh:

Year:  1988        PMID: 3259894      PMCID: PMC1041435          DOI: 10.1136/bjo.72.4.289

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  4 in total

1.  Orbital X-ray therapy of progressive exophthalmos.

Authors:  A JONES
Journal:  Br J Radiol       Date:  1951-12       Impact factor: 3.039

2.  Reticulo-endotheliosis of children: treatment with roentgen rays.

Authors:  D S CHILDS; R L J KENNEDY
Journal:  Radiology       Date:  1951-11       Impact factor: 11.105

3.  Supervoltage orbital radiotherapy for Graves' ophthalmopathy.

Authors:  S S Donaldson; M A Bagshaw; J P Kriss
Journal:  J Clin Endocrinol Metab       Date:  1973-08       Impact factor: 5.958

4.  Eosinophilic granuloma of bone; experience with 20 cases.

Authors:  S F Ochsner
Journal:  Am J Roentgenol Radium Ther Nucl Med       Date:  1966-07
  4 in total
  4 in total

Review 1.  Management of dysthyroid eye disease.

Authors:  P Fells
Journal:  Br J Ophthalmol       Date:  1991-04       Impact factor: 4.638

Review 2.  Radiotherapy and ophthalmology: time for a friendly re-acquaintance.

Authors:  P N Plowman
Journal:  Br J Ophthalmol       Date:  1992-05       Impact factor: 4.638

Review 3.  Graves' ophthalmopathy.

Authors:  B W Fleck; A D Toft
Journal:  BMJ       Date:  1990-05-26

4.  Thyroid eye disease. More treatment options.

Authors:  A N Harnett; A MacDonald; G N Dutton
Journal:  BMJ       Date:  1993-05-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.